Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities

Go back to Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities
(NASDAQ: TWST) Delayed: 155.56 +12.49 (8.73%)
Previous Close $143.07    52 Week High
Open $151.43    52 Week Low
Day High $163.70    P/E N/A 
Day Low $150.00    EPS
Volume 3,367,378